Medicare Coverage for Next-Generation Sequencing Tests Multigene panels that rely on next-generation sequencing are increasingly used to test for hereditary cancer risk-related mutations. The federal government aims to expand Medicare coverage for these tests. by Ashley P. Taylor On Cancer and Identity The first time Liza Bernstein was diagnosed with cancer, she wouldn’t allow it to be part of her identity. After her third cancer diagnosis, she became an advocate for other patients. by Liza Bernstein Telling Your Children About Inheritable Cancer Risk Letting children know they might have a mutation that increases their risk for cancer can be a challenge for patients. Experts stress there is no right or wrong way to share the information. by Marci A. Landsmann Turning Up the Heat on Cancer Researchers are working to expand the benefits of immunotherapy by making “cold” tumors “hot” so they can respond better to treatments. by Kendall K. Morgan Secure Connections Patients find each other online and get support they say is unparalleled, but with openness comes concern about privacy. by Kate Yandell BRCA: Who Should Be Tested? Genetic testing for mutations in the BRCA1 and BRCA2 genes creates opportunities for cancer risk reduction. But 25 years after the mutations were discovered, some who could benefit from testing are still left out. by Sue Rochman FORWARD LOOK Early Chemotherapy Dose Reductions May Affect Breast Cancer Outcomes New study explores impact of lowering dose due to side effects. by Jane Langille Cancer Patient Advocates Find Strength in Numbers Patient advocates have become a vital part of the San Antonio Breast Cancer Symposium. Opportunities for advocates continue to multiply. by Marci A. Landsmann Exploring Immunotherapy for Triple Negative Breast Cancer Following the approval of the first immunotherapy for breast cancer by the U.S. Food and Drug Administration in March 2019, experts at the San Antonio Breast Cancer Symposium discussed avenues for further development. by Marci A. Landsmann Possible New Treatments for Patients With Metastatic HER2-Positive Breast Cancer Studies presented at the San Antonio Breast Cancer Symposium show additional treatment options. by Marci A. Landsmann next Cancer Talk Testing Cancer Patients for the Coronavirus Cancer centers are taking advantage of their in-house molecular laboratories to selectively test certain cancer patients for the coronavirus. by Anna Azvolinsky The Coronavirus Impacts Cancer Clinical Trials The National Cancer Institute and the Food and Drug Administration have provided guidance for managing clinical trials amid the spread of the novel coronavirus. Cancer centers are making changes to care for some patients enrolled in trials. by Anna Azvolinsky A Unified Strategy A couple who lost their daughter to brain cancer builds a charity that connects parents, hospitals and researchers with data. by Marci A. Landsmann The Coronavirus and Cancer Care Cancer patients in the U.S. are feeling impacts from the new coronavirus. by Kate Yandell More Posts